Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
In Alzheimer disease (AD), amyloid precursor protein (APP) and production of amyloid beta
(Aβ) which is generated by amyloidogenic pathway is implicated in neurotoxicity and …
(Aβ) which is generated by amyloidogenic pathway is implicated in neurotoxicity and …
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
HM Al-Kuraishy, MS Jabir, AK Albuhadily… - Ageing Research …, 2024 - Elsevier
The ketogenic diet (KD) is a low-carbohydrate, adequate protein and high-fat diet. KD is
primarily used to treat refractory epilepsy. KD was shown to be effective in treating different …
primarily used to treat refractory epilepsy. KD was shown to be effective in treating different …
The classical and non-classical axes of renin-angiotensin system in Parkinson disease: the bright and dark side of the moon
HM Al-Kuraishy, SM Al-Hamash, MS Jabir… - Ageing Research …, 2024 - Elsevier
Parkinson disease (PD) is a common brain neurodegenerative disease due to progressive
degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). Of …
degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). Of …
[HTML][HTML] Role of fenofibrate in multiple sclerosis
Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the
central nervous system (CNS). The underlying pathophysiology of MS is the destruction of …
central nervous system (CNS). The underlying pathophysiology of MS is the destruction of …
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Z Al‐Qahtani, HM Al‐kuraishy… - Journal of Cellular …, 2024 - Wiley Online Library
Parkinson disease (PD) is one of the most common neurodegenerative diseases of the
brain. Of note, brain renin‐angiotensin system (RAS) is intricate in the PD neuropathology …
brain. Of note, brain renin‐angiotensin system (RAS) is intricate in the PD neuropathology …
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
NH Ali, HM Al‐Kuraishy, AI Al‐Gareeb… - Journal of Cellular …, 2024 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder of the brain and is manifested by
motor and non‐motor symptoms because of degenerative changes in dopaminergic …
motor and non‐motor symptoms because of degenerative changes in dopaminergic …
[HTML][HTML] Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
memory impairment and cognitive dysfunctions. It has been shown that hypoglycemia can …
memory impairment and cognitive dysfunctions. It has been shown that hypoglycemia can …
Depression and type 2 diabetes: A causal relationship and mechanistic pathway
WY Khawagi, HM Al‐kuraishy… - Diabetes, Obesity …, 2024 - Wiley Online Library
Depression is a mood disorder that may increase risk for the development of insulin
resistance (IR) and type 2 diabetes (T2D), and vice versa. However, the mechanistic …
resistance (IR) and type 2 diabetes (T2D), and vice versa. However, the mechanistic …
Cyclin‐dependent kinase 5 (CDK5) inhibitors in Parkinson disease
Abstract Cyclin‐dependent kinase 5 (Cdk5) is a protein expressed in postmitotic neurons in
the central nervous system (CNS). Cdk5 is activated by p35 and p39 which are neuron …
the central nervous system (CNS). Cdk5 is activated by p35 and p39 which are neuron …
[HTML][HTML] Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug …
The association between Alzheimer's disease and metabolic disorders as significant risk
factors is widely acknowledged. However, the intricate molecular mechanism intertwining …
factors is widely acknowledged. However, the intricate molecular mechanism intertwining …